Drug intelligence / Profile preview

EG-HZ-002

Development stage: Unknown
Lead developer: EyeGene
Modality: Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Peptide-based Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

EG-HZ-002 is a non-live, recombinant subunit vaccine candidate developed for the prevention of herpes zoster (shingles). It is part of a series of investigational vaccines (EG-HZ-001, EG-HZ-002, etc.) being studied in parallel arms. The vaccine is administered as two single intramuscular injections given two months apart. The broader program (EG HZ) utilizes recombinant varicella zoster virus glycoprotein E as the antigen and aims to stimulate an immune response to prevent reactivation of latent varicella zoster virus. The developer is EyeGene[2][3][4].

Targets

Hla (Staphylococcus aureus alpha toxin)

Beyond the preview

Go deeper on EG-HZ-002.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EG-HZ-002.

Explore the full profile